Literature DB >> 26568543

Molecular Aspects of Head and Neck Cancer Therapy.

Sidharth V Puram1, James W Rocco2.   

Abstract

In spite of a rapidly expanding understanding of head and neck tumor biology and optimization of radiation, chemotherapy, and surgical treatment modalities, head and neck squamous cell carcinoma (HNSCC) remains a major cause of cancer-related morbidity and mortality. Although our biologic understanding of these tumors had largely been limited to pathways driving proliferation, survival, and differentiation, the identification of HPV as a major driver of HNSCC and genomic sequencing analyses has dramatically influenced our understanding of tumor biology and approach to therapy. Here, we summarize molecular aspects of HNSCC biology and identify promising areas for potential diagnostic and therapeutic agents.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genomic sequencing; Head and neck cancer; Intratumor heterogeneity; Molecular biology; Squamous cell carcinoma; Synthetic lethality; Targeted therapy

Mesh:

Substances:

Year:  2015        PMID: 26568543      PMCID: PMC4648693          DOI: 10.1016/j.hoc.2015.07.003

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  96 in total

Review 1.  A continuum model for tumour suppression.

Authors:  Alice H Berger; Alfred G Knudson; Pier Paolo Pandolfi
Journal:  Nature       Date:  2011-08-10       Impact factor: 49.962

2.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.

Authors:  Lisa Licitra; Federica Perrone; Paolo Bossi; Simona Suardi; Luigi Mariani; Raffaella Artusi; Maria Oggionni; Chiara Rossini; Giulio Cantù; Massimo Squadrelli; Pasquale Quattrone; Laura D Locati; Cristiana Bergamini; Patrizia Olmi; Marco A Pierotti; Silvana Pilotti
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

3.  Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.

Authors:  K Okami; L Wu; G Riggins; P Cairns; M Goggins; E Evron; N Halachmi; S A Ahrendt; A L Reed; W Hilgers; S E Kern; W M Koch; D Sidransky; J Jen
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

4.  Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma.

Authors:  James W Rocco
Journal:  Head Neck Pathol       Date:  2015-03-25

5.  DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1.

Authors:  Sarah A Martin; Nuala McCabe; Michelle Mullarkey; Robert Cummins; Darren J Burgess; Yusaku Nakabeppu; Sugako Oka; Elaine Kay; Christopher J Lord; Alan Ashworth
Journal:  Cancer Cell       Date:  2010-03-16       Impact factor: 31.743

6.  Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma.

Authors:  X Shao; R Tandon; G Samara; H Kanki; H Yano; L G Close; R Parsons; T Sato
Journal:  Int J Cancer       Date:  1998-08-31       Impact factor: 7.396

7.  Frequent p53 mutations in head and neck cancer.

Authors:  K D Somers; M A Merrick; M E Lopez; L S Incognito; G L Schechter; G Casey
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

8.  Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors.

Authors:  Yin Zhang; Manfred Jung; Anatoly Dritschilo; Mira Jung
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

9.  Molecular basis for CD40 signaling mediated by TRAF3.

Authors:  C Z Ni; K Welsh; E Leo; C K Chiou; H Wu; J C Reed; K R Ely
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

10.  Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2.

Authors:  Sarah A Martin; Afshan McCarthy; Louise J Barber; Darren J Burgess; Suzanne Parry; Christopher J Lord; Alan Ashworth
Journal:  EMBO Mol Med       Date:  2009-09       Impact factor: 12.137

View more
  19 in total

Review 1.  Leveraging Genomics for Head and Neck Cancer Treatment.

Authors:  J D Kemmer; D E Johnson; J R Grandis
Journal:  J Dent Res       Date:  2018-02-08       Impact factor: 6.116

2.  Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma.

Authors:  Tatevik R Broutian; Bo Jiang; Jingfeng Li; Keiko Akagi; Shanying Gui; Zhengqiu Zhou; Weihong Xiao; David E Symer; Maura L Gillison
Journal:  Cancer Lett       Date:  2020-01-17       Impact factor: 8.679

3.  The utility of intra-oral ultrasound in improving deep margin clearance of oral tongue cancer resections.

Authors:  Mustafa G Bulbul; Osama Tarabichi; Anuraag S Parikh; Byung C Yoon; Amy Juliano; Peter M Sadow; William Faquin; Matthew Gropler; Ronald Walker; Sidharth V Puram; Mark A Varvares
Journal:  Oral Oncol       Date:  2021-09-23       Impact factor: 5.972

4.  Low-risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: Equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone.

Authors:  Reilly A Sample; Carey Burton Wood; Angela L Mazul; Thomas F Barrett; Randal C Paniello; Jason T Rich; Stephen Y Kang; Jose Zevallos; Mackenzie D Daly; Wade L Thorstad; Stephanie Y Chen; Patrik Pipkorn; Ryan S Jackson; Sidharth V Puram
Journal:  Head Neck       Date:  2021-02-15       Impact factor: 3.821

Review 5.  The clinical and prognostic significance of CMTM6/PD-L1 in oncology.

Authors:  Mahmoud Mohammad Yaseen; Nizar Mohammad Abuharfeil; Homa Darmani
Journal:  Clin Transl Oncol       Date:  2022-03-12       Impact factor: 3.340

Review 6.  No association of TNF-α-308G/A polymorphisms with head and neck cancer risk: A PRISMA-compliant meta-analysis.

Authors:  Cheng Yuan; Xin-Hua Xu; Lu Xu; Yang Liu; Min Sun; Li-Hua Ni; Xiao-Long Wang; Zhuo Chen; Kun Zhang; Guang Zeng
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

7.  MiR-146a rs2910164 polymorphism and head and neck carcinoma risk: a meta-analysis based on 10 case-control studies.

Authors:  Zhaolan Xiang; Jue Song; Xianlu Zhuo; Qi Li; Xueyuan Zhang
Journal:  Oncotarget       Date:  2017-01-03

8.  JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma.

Authors:  Lucas de Lima Maia; Gabriela Tonini Peterle; Marcelo Dos Santos; Leonardo Oliveira Trivilin; Suzanny Oliveira Mendes; Mayara Mota de Oliveira; Joaquim Gasparini Dos Santos; Elaine Stur; Lidiane Pignaton Agostini; Cinthia Vidal Monteiro da Silva Couto; Juliana Dalbó; Aricia Leone Evangelista Monteiro de Assis; Anderson Barros Archanjo; Ana Maria Da Cunha Mercante; Rossana Veronica Mendoza Lopez; Fábio Daumas Nunes; Marcos Brasilino de Carvalho; Eloiza Helena Tajara; Iúri Drumond Louro; Adriana Madeira Álvares-da-Silva
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

9.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer.

Authors:  Sidharth V Puram; Itay Tirosh; Anuraag S Parikh; Anoop P Patel; Keren Yizhak; Shawn Gillespie; Christopher Rodman; Christina L Luo; Edmund A Mroz; Kevin S Emerick; Daniel G Deschler; Mark A Varvares; Ravi Mylvaganam; Orit Rozenblatt-Rosen; James W Rocco; William C Faquin; Derrick T Lin; Aviv Regev; Bradley E Bernstein
Journal:  Cell       Date:  2017-11-30       Impact factor: 41.582

10.  Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.

Authors:  Huanhuan Wang; Qin Zhao; Yuyu Zhang; Qihe Zhang; Zhuangzhuang Zheng; Shiyu Liu; Zijing Liu; Lingbin Meng; Ying Xin; Xin Jiang
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.